EXIRIS
Desconocido
Magicbullet Reloaded: Small Molecule Drug Conjugates for Targeted Delivery in Tumor Therapy
EXIRIS SRL
participó en un
H2020:
H2020-MSCA-ITN-2019
"Despite the continuing development of new and more efficient treatments, cancer remains the second cause of premature death worldwide. Mult...
2019-09-11 - 2024-04-30 | Financiado
2019-09-11 - 2024-04-30 | Financiado
MAGICBULLET: Peptide Drug Conjugates for Targeted Delivery in Tumor Therapy
EXIRIS SRL
participó en un
H2020:
H2020-MSCA-ITN-2014
Many tumor cells are characterized by the overexpression of certain antigens. Molecules that specifically recognize these structures are sui...
2014-12-05 - 2018-12-31 | Financiado
2014-12-05 - 2018-12-31 | Financiado
* No se disponen de datos de la empresa actual.